Bryan Johnson’s ongoing relationship with Blueprint co-founder Kate Tolo remains the central driver of market sentiment for time-bound “have sex again” contracts. The couple continues to appear together publicly, with Johnson documenting intimacy-linked biomarkers such as prolactin surges, oxytocin, and improved vagal tone as recently as mid-2026, alongside routine oversharing of her microbiome scores and menstrual-blood samples stored for analysis. His protocol explicitly tracks sexual-health metrics—erections, testosterone trends, and recovery scores—treating them as quantifiable longevity inputs rather than private matters. No credible reports of separation have surfaced, and recent X activity referencing Tolo indicates continuity. Key near-term catalysts include any joint protocol updates, conference appearances, or relationship-status posts that could shift trader consensus on whether public confirmation arrives before resolution deadlines.